New Waived Tests for 2014
The CPT® codes the Centers for Medicare & Medicaid Services (CMS) considers to be laboratory tests under the Clinical Laboratory Improvement Amendments of 1998 (CLIA) change each year. CMS released, April 4, the latest CLIA-waived tests approved by the FDA.
Among them is new CPT® code 83516, assigned for the immunoassay test used to confirm a suspected diagnosis of dry eye.
In addition to including the CLIA number for each waived test on a claim, you must append modifier QW CLIA waived test to each of the following CPT® codes for them to be recognized as waived tests.
|87880QW||July 29, 2013||Poly stat Strep A Flip Test|
|G0434QW||August 1, 2013||Alere iScreen DX Multi-Drugs of Abuse Dip Test|
|G0434QW||September 10, 2013||Alere iScreen DX Single Dip Card (the Alere iScreen DX Single Dip Card may include a maximum of four drugs in any combination of the 13 claimed drugs)|
|85018QW||December 12, 2013||Alere HemoPoint H2 System|
|87804QW||December 13, 2013||Sofia Analyzer and Influenza A+B FIA|
|G0434QW||February 21, 2014||Ultimate Analysis Cup Inc. UA Cups Test Cards|
|G0434QW||February 21, 2014||Ultimate Analysis Cup Inc. UA Cups|
|83516QW||February 27, 2014||Rapid Pathogen Screening, Inc. InflammaDry|
These codes have retroactive effective dates. Medicare administrative contractors (MACs) are not required to make good on claims you have already submitted for reimbursement. MACs, however, are required to reconsider all such claims brought to their attention.
Source: MLN Matters® MM8705
Latest posts by Renee Dustman (see all)
- CMS Reports OPPS Hospital Claim Issues - January 20, 2017
- Coding Glaucoma Preventive Screening - January 20, 2017
- Dear Trump Administration: A Vision for the Future of Healthcare - January 18, 2017